141 related articles for article (PubMed ID: 31953417)
1. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
[TBL] [Abstract][Full Text] [Related]
2. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
4. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
5. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
Chen S; Wang J; Yang L; Ji M; Chen S
J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
[TBL] [Abstract][Full Text] [Related]
8. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
9. Medullary carcinoma of the breast: a population-based perspective.
Martinez SR; Beal SH; Canter RJ; Chen SL; Khatri VP; Bold RJ
Med Oncol; 2011 Sep; 28(3):738-44. PubMed ID: 20390465
[TBL] [Abstract][Full Text] [Related]
10. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract][Full Text] [Related]
12. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
13. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
14. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
J Surg Oncol; 2016 Oct; 114(5):533-536. PubMed ID: 27393599
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
[TBL] [Abstract][Full Text] [Related]
16. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
17. Distant metastasis and prognostic factors in patients with invasive ductal carcinoma of the breast.
Chen X; Zhang C; Guo D; Wang Y; Hu J; Hu J; Wang S; Liu X
Eur J Clin Invest; 2022 Apr; 52(4):e13704. PubMed ID: 34725819
[TBL] [Abstract][Full Text] [Related]
18. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
Cook DL; Weaver DL
Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
[TBL] [Abstract][Full Text] [Related]
19. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
[TBL] [Abstract][Full Text] [Related]
20. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]